P52948 (NUP98_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 147.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Nuclear pore complex protein Nup98-Nup96 Cleaved into the following 2 chains:
| ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1817 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance. Nup98 and Nup96 are involved in the bidirectional transport across the NPC. May anchor NUP153 and TPR to the NPC. Ref.18 |
| Subunit structure | Part of the nuclear pore complex (NPC). Nup98 interacts directly with Nup96. Nup98 interacts directly with NUP88 and NUP214, subunits of the cytoplasmic filaments of the NPC By similarity. Nup96 is part of the Nup160 subcomplex in the nuclear pore which is composed of NUP160, NUP133, NUP107 and Nup96. This complex plays a role in RNA export and in tethering Nup98 and NUP153 to the nucleus. Interacts with RAE1. Does not interact with TPR. Interacts with vesicular stomatitis virus protein M. Ref.11 Ref.12 Ref.14 Ref.17 Ref.18 Ref.34 Ref.35 |
| Subcellular location | Nucleus. Nucleus membrane; Peripheral membrane protein; Nucleoplasmic side. Nucleus › nuclear pore complex. Note: Nup96 is localized to the nucleoplasmic side of the nuclear pore complex (NPC), at or near the nucleoplasmic basket. Dissociates from the dissasembled NPC structure early during prophase of mitosis. Colocalized with NUP153 and TPR to the nuclear basket of NPC. Detected in diffuse and discrete intranuclear foci. Remained localized to the nuclear membrane after poliovirus (PV) infection. Ref.16 Ref.17 Ref.18 Ref.30 |
| Domain | Contains G-L-F-G repeats. The FG repeat domains in Nup98 have a direct role in the transport. |
| Post-translational modification | Isoform 1 to isoform 4 are autoproteolytically cleaved to yield Nup98 and Nup96 or Nup98 only, respectively. Cleaved Nup98 is necessary for the targeting of Nup98 to the nuclear pore and the interaction with Nup96. Ref.30 Ref.35 Proteolytically degraded after poliovirus (PV) infection; degradation is partial and NCP- and TPR-binding domains withstand degradation. |
| Involvement in disease | A chromosomal aberration involving NUP98 is found in a form of acute myeloid leukemia. Translocation t(7;11)(p15;p15) with HOXA9. Translocation t(11;17)(p15;p13) with PHF23. A chromosomal aberration involving NUP98 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NSD1. Translocation t(8;11)(p11.2;p15) with WHSC1L1. A chromosomal aberration involving NUP98 is found in a form of therapy-related myelodysplastic syndrome. Translocation t(11;20)(p15;q11) with TOP1. A chromosomal aberration involving NUP98 is found in a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(3;11)(q12.2;p15.4) with LNP1. A chromosomal aberration involving NUP98 is associated with pediatric acute myeloid leukemia (AML) with intermediate characteristics between M2-M3 French-American-British (FAB) subtypes. Translocation t(9;11)(p22;p15) with PSIP1/LEDGF. The chimeric transcript is an in-frame fusion of NUP98 exon 8 to PSIP1/LEDGF exon 4. |
| Sequence similarities | Belongs to the nucleoporin GLFG family. Contains 1 peptidase S59 domain. |
| Sequence caution | The sequence AAD22395.1 differs from that shown. Reason: Contaminating sequence. Sequence of unknown origin in the C-terminal part. The sequence AAD22396.1 differs from that shown. Reason: Contaminating sequence. Sequence of unknown origin in the C-terminal part. The sequence AAF19342.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence AAF19342.1 differs from that shown. Reason: Frameshift at position 1551. |
Ontologies
Alternative products
| This entry describes 6 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P52948-1) Also known as: Nup98-Nup96 precursor; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P52948-2) Also known as: Nup98-Nup96 precursor splice variant 1; The sequence of this isoform differs from the canonical sequence as follows: 393-409: Missing. 1502-1576: RHYDLNQLLE...FVLLHIDNSG → S | ||||||
| Isoform 3 (identifier: P52948-3) Also known as: Nup98-specific 1; The sequence of this isoform differs from the canonical sequence as follows: 932-937: SQSPEV → VEKKGQ 938-1817: Missing. | ||||||
| Isoform 4 (identifier: P52948-4) The sequence of this isoform differs from the canonical sequence as follows: 393-409: Missing. 932-937: SQSPEV → VEKKGQ 938-1817: Missing. | ||||||
| Isoform 5 (identifier: P52948-5) Also known as: Nup196; ADIR2; The sequence of this isoform differs from the canonical sequence as follows: 393-409: Missing. | ||||||
| Isoform 6 (identifier: P52948-6) The sequence of this isoform differs from the canonical sequence as follows: 1085-1188: WSVPPPLTSV...FLPNPVAVKP → C |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 880 | 880 | Nuclear pore complex protein Nup98 | PRO_0000019929 | ||||||||||||||||||||||||||||||||||||||||||
| Chain | 881 – 1817 | 937 | Nuclear pore complex protein Nup96 | PRO_0000019930 | ||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 738 – 880 | 143 | Peptidase S59 | |||||||||||||||||||||||||||||||||||||||||||
| Region | 1 – 156 | 156 | FG repeats 1 | |||||||||||||||||||||||||||||||||||||||||||
| Region | 157 – 213 | 57 | GLEBS; interaction with RAE1 | |||||||||||||||||||||||||||||||||||||||||||
| Region | 214 – 480 | 267 | FG repeats 2 | |||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 7 – 480 | 474 | Gly/Thr-rich | |||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 890 – 894 | 5 | Poly-Glu | |||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||
| Site | 531 – 532 | 2 | Breakpoint for translocation to form NUP98-PHF23 oncogene | |||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 524 | 1 | Phosphoserine Ref.31 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 603 | 1 | N6-acetyllysine Ref.29 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 608 | 1 | Phosphoserine Ref.20 Ref.22 Ref.24 Ref.28 Ref.31 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 612 | 1 | Phosphoserine Ref.20 Ref.22 Ref.24 Ref.28 Ref.31 Ref.33 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 618 | 1 | Phosphoserine Ref.28 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 623 | 1 | Phosphoserine Ref.22 Ref.26 Ref.28 Ref.31 Ref.33 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 625 | 1 | Phosphoserine Ref.28 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 670 | 1 | Phosphothreonine Ref.31 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 673 | 1 | Phosphoserine Ref.31 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 681 | 1 | Phosphoserine Ref.31 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 683 | 1 | Phosphoserine Ref.33 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 839 | 1 | Phosphoserine Ref.20 Ref.26 Ref.31 Ref.33 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 888 | 1 | Phosphoserine Ref.20 Ref.25 Ref.26 Ref.27 Ref.31 Ref.33 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 934 | 1 | Phosphoserine Ref.26 Ref.31 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1000 | 1 | Phosphothreonine Ref.26 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1023 | 1 | Phosphoserine Ref.26 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1028 | 1 | Phosphoserine Ref.22 Ref.26 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1043 | 1 | Phosphoserine Ref.26 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1060 | 1 | Phosphoserine Ref.22 Ref.26 | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1070 | 1 | Phosphothreonine Ref.26 | |||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 393 – 409 | 17 | Missing in isoform 2, isoform 4 and isoform 5. | VSP_003619 | ||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 932 – 937 | 6 | SQSPEV → VEKKGQ in isoform 3 and isoform 4. | VSP_007942 | ||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 938 – 1817 | 880 | Missing in isoform 3 and isoform 4. | VSP_007943 | ||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1085 – 1188 | 104 | WSVPP…VAVKP → C in isoform 6. | VSP_038328 | ||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1502 – 1576 | 75 | RHYDL…IDNSG → S in isoform 2. | VSP_007944 | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1669 | 1 | G → V in a breast cancer sample; somatic mutation. Ref.37 | VAR_035859 | ||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 318 | 1 | L → S in AAH41136. Ref.6 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 376 | 1 | S → G in AAH41136. Ref.6 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 756 – 757 | 2 | EK → VF in AAD22395. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 756 – 757 | 2 | EK → VF in AAD22396. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1281 | 1 | G → A in AAD22395. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1281 | 1 | G → A in AAD22396. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1281 | 1 | G → A in AAL56659. Ref.4 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1534 – 1536 | 3 | ALN → DLK in AAD22395. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1594 | 1 | E → D in AAF19342. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1598 | 1 | S → T in AAL56659. Ref.4 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1639 | 1 | K → N in AAF19342. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1680 | 1 | S → T in AAF19342. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 168 – 172 | 5 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 181 – 186 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 189 – 191 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 193 – 197 | 5 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 200 – 209 | 10 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 741 – 745 | 5 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 747 – 753 | 7 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 761 – 769 | 9 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 770 – 772 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 773 – 782 | 10 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 788 – 791 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 792 – 795 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 798 – 801 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 805 – 807 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 819 – 823 | 5 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 831 – 833 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 840 – 845 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 848 – 858 | 11 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 862 – 867 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 868 – 871 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 872 – 879 | 8 | ||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9." Borrow J., Shearman A.M., Stanton V.P., Becher R., Collins T., Williams A.J., Dube I., Katz F., Kwong Y.L., Morris C., Ohyashiki K., Toyama K., Rowley J., Housman D.E. Nat. Genet. 12:159-167(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), CHROMOSOMAL TRANSLOCATION WITH HOXA9. |
| [2] | "Molecular analysis of the chromosomal breakpoints and identification of the repetitive sequences near the breakpoints of NUP98 in therapy-related leukemia with inv(11)(p15q22)." Arai Y., Kaneko Y., Kubo T., Arai K., Hosoda F., Ohki M. Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [3] | "A conserved biogenesis pathway for nucleoporins: proteolytic processing of a 186-kilodalton precursor generates Nup98 and the novel nucleoporin, Nup96." Fontoura B.M.A., Blobel G., Matunis M.J. J. Cell Biol. 144:1097-1112(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF 1648-1664. |
| [4] | "An alternative splice form of NUP98 encodes a 196kDa NUP196 isoform." Borrow J., Housman D.E. Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). |
| [5] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 963-1817 (ISOFORM 6). Tissue: Lung carcinoma. |
| [7] | Xu Y.H., Guo B.C., Yu Y.L. Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1176-1817 (ISOFORM 5). Tissue: Liver. |
| [8] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1212-1817 (ISOFORM 5). |
| [9] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1227-1817 (ISOFORM 5). Tissue: Testis. |
| [10] | "The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion." Ahuja H.G., Felix C.A., Aplan P.D. Blood 94:3258-3261(1999) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH TOP1. |
| [11] | "RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains." Pritchard C.E., Fornerod M., Kasper L.H., van Deursen J.M. J. Cell Biol. 145:237-254(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RAE1. |
| [12] | "Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98." von Kobbe C., van Deursen J.M., Rodrigues J.P., Sitterlin D., Bachi A., Wu X., Wilm M., Carmo-Fonseca M., Izaurralde E. Mol. Cell 6:1243-1252(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH VESICULAR STOMATITIS VIRUS PROTEIN M. |
| [13] | "A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia." Jaju R.J., Fidler C., Haas O.A., Strickson A.J., Watkins F., Clark K., Cross N.C., Cheng J.F., Aplan P.D., Kearney L., Boultwood J., Wainscoat J.S. Blood 98:1264-1267(2001) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH NSD1. |
| [14] | "Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export." Vasu S., Shah S., Orjalo A., Park M., Fischer W.H., Forbes D.J. J. Cell Biol. 155:339-354(2001) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT. |
| [15] | "NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)." Rosati R., La Starza R., Veronese A., Aventin A., Schwienbacher C., Vallespi T., Negrini M., Martelli M.F., Mecucci C. Blood 99:3857-3860(2002) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH WHSC1L1. |
| [16] | "Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export." Frosst P., Guan T., Subauste C., Hahn K., Gerace L. J. Cell Biol. 156:617-630(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [17] | "Direct interaction with nup153 mediates binding of Tpr to the periphery of the nuclear pore complex." Hase M.E., Cordes V.C. Mol. Biol. Cell 14:1923-1940(2003) [PubMed] [Europe PMC] [Abstract] Cited for: ABSENCE OF INTERACTION WITH TPR, SUBCELLULAR LOCATION. |
| [18] | "Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket." Krull S., Thyberg J., Bjorkroth B., Rackwitz H.R., Cordes V.C. Mol. Biol. Cell 15:4261-4277(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE NUCLEAR PORE COMPLEX, SUBCELLULAR LOCATION. |
| [19] | "t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia." Morerio C., Acquila M., Rosanda C., Rapella A., Tassano E., Micalizzi C., Panarello C. Leuk. Res. 29:467-470(2005) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH PSIP1/LEDGF. |
| [20] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-608; SER-612; SER-839 AND SER-888, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [21] | "NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique." Romana S.P., Radford-Weiss I., Ben Abdelali R., Schluth C., Petit A., Dastugue N., Talmant P., Bilhou-Nabera C., Mugneret F., Lafage-Pochitaloff M., Mozziconacci M.-J., Andrieu J., Lai J.-L., Terre C., Rack K., Cornillet-Lefebvre P., Luquet I., Nadal N. Berger R.Leukemia 20:696-706(2006) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH LNP1. |
| [22] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-608; SER-612; SER-623; SER-1028 AND SER-1060, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [23] | "A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia." Reader J.C., Meekins J.S., Gojo I., Ning Y. Leukemia 21:842-844(2007) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH PHF23. Tissue: Peripheral blood. |
| [24] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-608 AND SER-612, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-888, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [26] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-623; SER-839; SER-888; SER-934; THR-1000; SER-1023; SER-1028; SER-1043; SER-1060 AND THR-1070, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [27] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-888, MASS SPECTROMETRY. Tissue: Liver. |
| [28] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-608; SER-612; SER-618; SER-623 AND SER-625, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [29] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-603, MASS SPECTROMETRY. |
| [30] | "Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion." Krull S., Dorries J., Boysen B., Reidenbach S., Magnius L., Norder H., Thyberg J., Cordes V.C. EMBO J. 29:1659-1673(2010) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING. |
| [31] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524; SER-608; SER-612; SER-623; THR-670; SER-673; SER-681; SER-839; SER-888 AND SER-934, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [32] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [33] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-612; SER-623; SER-683; SER-839 AND SER-888, MASS SPECTROMETRY. |
| [34] | "The three-dimensional structure of the autoproteolytic, nuclear pore-targeting domain of the human nucleoporin Nup98." Hodel A.E., Hodel M.R., Griffis E.R., Hennig K.A., Ratner G.A., Xu S., Powers M.A. Mol. Cell 10:347-358(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 710-870 OF NUP98, INTERACTION WITH NUP96. |
| [35] | "Structural constraints on autoprocessing of the human nucleoporin Nup98." Sun Y., Guo H.C. Protein Sci. 17:494-505(2008) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 733-887, SUBUNIT, AUTOPROTEOLYTIC PROCESSING. |
| [36] | "Structural and functional analysis of the interaction between the nucleoporin Nup98 and the mRNA export factor Rae1." Ren Y., Seo H.S., Blobel G., Hoelz A. Proc. Natl. Acad. Sci. U.S.A. 107:10406-10411(2010) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 158-213 IN COMPLEX WITH RAE1. |
| [37] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] VAL-1669. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U41815 mRNA. Translation: AAC50366.1. AB040538 mRNA. Translation: BAB18537.1. AF071076 mRNA. Translation: AAD22395.1. Sequence problems. AF071077 mRNA. Translation: AAD22396.1. Sequence problems. AF231130 mRNA. Translation: AAL56659.1. AC060812 Genomic DNA. No translation available. AC090587 Genomic DNA. No translation available. BC041136 mRNA. Translation: AAH41136.1. BC012906 mRNA. Translation: AAH12906.2. AF116074 mRNA. Translation: AAF19342.1. Sequence problems. BT007349 mRNA. Translation: AAP36013.1. AL133601 mRNA. Translation: CAB63736.1. AL137613 mRNA. Translation: CAB70842.1. | ||||||||||||||||||||||||||||||||||||
| IPI | IPI00006038. IPI00216688. IPI00337395. IPI00337397. IPI00936708. IPI00953181. | ||||||||||||||||||||||||||||||||||||
| PIR | T43443. | ||||||||||||||||||||||||||||||||||||
| RefSeq | NP_005378.4. NM_005387.5. NP_057404.2. NM_016320.4. NP_624357.1. NM_139131.3. NP_624358.2. NM_139132.3. | ||||||||||||||||||||||||||||||||||||
| UniGene | Hs.524750. | ||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | P52948. | ||||||||||||||||||||||||||||||||||||
| SMR | P52948. Positions 158-213, 729-880. | ||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||
| DIP | DIP-32484N. | ||||||||||||||||||||||||||||||||||||
| IntAct | P52948. 13 interactions. | ||||||||||||||||||||||||||||||||||||
| MINT | MINT-121544. | ||||||||||||||||||||||||||||||||||||
Protein family/group databases | |||||||||||||||||||||||||||||||||||||
| MEROPS | S59.001. | ||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||
| PhosphoSite | P52948. | ||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||
| DMDM | 308153660. | ||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||
| PaxDb | P52948. | ||||||||||||||||||||||||||||||||||||
| PRIDE | P52948. | ||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||
| DNASU | 4928. | ||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000324932; ENSP00000316032; ENSG00000110713. ENST00000355260; ENSP00000347404; ENSG00000110713. ENST00000397004; ENSP00000380199; ENSG00000110713. ENST00000397007; ENSP00000380202; ENSG00000110713. | ||||||||||||||||||||||||||||||||||||
| GeneID | 4928. | ||||||||||||||||||||||||||||||||||||
| KEGG | hsa:4928. | ||||||||||||||||||||||||||||||||||||
| UCSC | uc001lyh.3. human. uc001lyi.3. human. uc001lyj.2. human. uc001lyk.2. human. | ||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||
| CTD | 4928. | ||||||||||||||||||||||||||||||||||||
| GeneCards | GC11M003696. | ||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:8068. NUP98. | ||||||||||||||||||||||||||||||||||||
| MIM | 601021. gene. | ||||||||||||||||||||||||||||||||||||
| neXtProt | NX_P52948. | ||||||||||||||||||||||||||||||||||||
| PharmGKB | PA31856. | ||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||
| eggNOG | NOG12793. | ||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG052702. | ||||||||||||||||||||||||||||||||||||
| KO | K14297. | ||||||||||||||||||||||||||||||||||||
| OMA | VNRDSED. | ||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||
| Reactome | REACT_111217. Metabolism. REACT_115566. Cell Cycle. REACT_116125. Disease. REACT_15518. Transmembrane transport of small molecules. REACT_21300. Mitotic M-M/G1 phases. REACT_6900. Immune System. | ||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||
| ArrayExpress | P52948. | ||||||||||||||||||||||||||||||||||||
| Bgee | P52948. | ||||||||||||||||||||||||||||||||||||
| Genevestigator | P52948. | ||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000110713. Homo sapiens. | ||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||
| InterPro | IPR021967. Nup96. IPR007230. Peptidase_S59. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| Pfam | PF04096. Nucleoporin2. 1 hit. PF12110. Nup96. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF82215. Peptidase_S59. 1 hit. | ||||||||||||||||||||||||||||||||||||
| PROSITE | PS51434. NUP_C. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||
| ChiTaRS | NUP98. human. | ||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | P52948. | ||||||||||||||||||||||||||||||||||||
| GenomeRNAi | 4928. | ||||||||||||||||||||||||||||||||||||
| NextBio | 18979. | ||||||||||||||||||||||||||||||||||||
| PMAP-CutDB | P52948. | ||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | NUP98_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P52948 Secondary accession number(s): Q8IUT2 Q9Y6J5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
